Member Info for saintpeter7

“We have completed work ahead of schedule on our new tailings facility and are depositing tailings at Camp Pond under manual control as of July 18. The tailings project included some critical control components necessary to sustain milling rates in excess of 1,400 dry tonnes per day and these will be in place and operational by August 31”. Taken from the RNS of 9 August. That helps if on time as I expect it should be, having been announced only 22 days earlier.

Shares seem to be gradually absorbed at 1p.

May have disappointed one or two holders and 2019 FY could show forecast revenues of £2mln for Eden rising to £3.6mln in 2020 and then £6.6mln in 2021.

However, analysts said they had forecast the company’s figures “conservatively”, and saw the potential for Eden to deliver 2019 revenues of up to £3.5mln depending on various outcomes including “upfront payments, milestones and sales currently dependent upon regulatory approval”.

Difficult to predict what FY 2019's revenue could be, but looking ahead to 2020, by which time the US EPA will hopefully have approved Mevalone and Cedroz for use in the US, a major market, looking very rosy.

https://www.proactiveinvestors.co.uk/companies/news/901648/eden-research-set-to-enter-period-of-strong-product-sales-growth-says-cenkos-901648.html

#HZM SP closed gap on daily chart today. #UPL to do likewise this year IMHO with so much potential.

Gap up to 3.1p currently c. 2p. Nice 50% to look forward to.

Has anyone heard about any further developments on the GridX JV since the announcement in April. Their website makes no mention of the deal.

Great new video just released by Immotion to publicise to aquariums around the world the boost that it can bring to their revenue. https://immotion.co.uk/aquarium/

Of course good for Immotion with normal 50:50 revenue split. Although they already have some VR, Georgia Aquarium one of the biggest in the US with over 2.2 million visitors ( 2016 figure) would be another good one to have over the pond.

Well said horsetrader2. See we had 9 buys and 5 sells today. Mms trying to show more sells by raising the offer price.

I have to correct my earlier post in that Shedd’s footfall was above 2 million not 3, but still Immotion’s share of revenue would be at least £500k per annum.

Note that the much smaller Mote has said that they have experienced 10% of their visitors using the headsets.

Don’t suppose that the O2 will produce such a percentage but even with 5% based on 9m visitors Immotion might achieve annual revenue of over £1m.

Am very much looking forward to the next results and/or aquarium/ zoo sign-up. The Congo river experience will suit zoos well, whilst the swimming with sharks will add great content to the aquariums with swimming with whales already in place.

Shedd aquarium quoting between 9% and 14% of visitors using Immotion’s headsets. Backs up what Martin Higginson says in his voxcast. With over 3 million visitors per year, that could mean that we might have over 300,000 uses at $6 per time revenue of $1.8m per annum to Shedd. Don’t know split between us and them but say 50:50 would mean $900,000 to Immotion I.e. c. £750,000 per annum.

Waiting for the US EPA approval for the Mevalone and Cedroz. When that comes investors will be royally rewarded for their patience. Great that we already have emergency use in both France and Italy for Mevalone and Cedroz respectively. The EPA’s scientific reviews are expected to be completed before the end of 2019. The USA is the largest market in the world for crop protection products and is a major producer of grapes, and the addition of this important country to our commercial footprint is expected to contribute meaningfully to the Company’s revenue in the years to come. Now, with commercial partners in place, we only await the regulatory clearance before sales can commence. Additional product commercialisation opportunities for new products are expected to be possible once approval of the three active ingredients is granted.

Although small, trade at 10.09 was my buy.

https://www.investegate.co.uk/deepmatter-group-plc--dmtr-/rns/first-revenues-for-digitalglassware/201908080700043125I/

https://m.youtube.com/watch?feature=youtu.be&v=EGNzcAn-mZE

It is encouraging that we have the new commercial director with his undoubtedly targeted expertise. Also that the Chairman has spent just under £40k in acquiring shares for the first time. Good signs for this second half of 2019.

Hi all. Have been researching Eden and it could have a bright future. I can see that Paolo in particular knows a lot about the company.

The FDA approval of Mevalone and Cedroz is obviously important and I understand that it is hoped to be received this year and that once approved, the arrangements with Sipcam and Eastman are such that commercial sales might start before the end of the year in the US or in Q1 2020.

It was interesting to note that the emergency approval of Cedroz in Italy for 120 days does take its use up to the end of the growing season.

One question I have is what are your thoughts on the 2019 revenue. It is pure guesswork on what sales may be. An increase of 50% at least would be helpful. My concern at present is that there does not appear to be any likelihood of any milestone payments or option fees this year. Do we know otherwise?

Well done horsetrader2 should hopefully be good time. Liked Immotion's tweet on Friday, https://twitter.com/Immotion_Group/status/1152251006148915200?s=20

Sounds as if it won't be that long before the second in the Blue Ocean series is released.

Plenty of tweeting this weekend by Immotion to advertise their O2 set-up. With a footfall of c. 9 million a year, this should be a real money-spinner.

See they have leased a new office in Manchester announced a couple of days ago. I assume space additional to their current offices.

Hi wressmycase. Funny I hadn’t looked on here for at least a month and the night I do is after your post. Like to think we hear something soon. The company has been deadly quiet. Would like to think that ME Group is nearing ready to be brought to market but wtfdik.

The trades at 8.15p were buys as one of them was mine.

Share has found good support at 8p and daily chart indicates we are due for a rise in the SP with MACD cross over imminent and RSI stoch low.

Even if you are not someone who follows charts, the company's fundamentals are very good, with revenue growing fast and approaching break-even at the profit level with numbers of headsets/pods set to rise above break-even number of 350 - 400 (according to CEO MH) before the end of the year; I suspect in the next month or two.

Excellent opportunity IMHO.

Update - Been informed that Al Hokair now have over 100 family entertainment centres and generate over 10m visitors per year and of course these visitors are high earners and in the high disposable income category.

https://www.alhokair.com/Business/Entertainment - 64 potential entertainment centres for Immotion to have their VR pods set up. Some already set up in Sparkys, part of Al Hokair's entertainment centres.

Immotion has seen tremendous expansion this year starting at 46 headsets/pods in the concessions - now more than 250 I understand and closing in on breakeven level of 350 - 400 fast. That undoubtedly could happen in the next couple of months. Once in place, further headsets/pods will put the company in a profitable position, the further revenue largely going to the bottom line according to CEO Martin Higginson.

We are waiting to hear of extension of Merlin/Sealife sites for more headsets/pods.

Add to that source of revenue you have the licensing agreement with the AAA entertainment business ip2Entertainment generating c.$500,000.

Exciting prospect.